Najnowsze wersje próbne


EudraCT Number: 2004-001583-52 Sponsor Protocol Number: Intu Start Date: 2004-09-22
Sponsor Name: Lund University Hospital
Full Title: Balanced anestesia for intubation of newborn premature infants – a randomized intervention study Balanserad anestesi för intubation av nyfödda prematura barn – en randomiserad interventionsstudie
Medical condition: Respiratory insufficiency in prematrue infants requiring ventilatory assistance and therefore intubation. Premedication before intubation.
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: (No results available)

EudraCT Number: 2005-000393-47 Sponsor Protocol Number: SP000680 Start Date: 2004-09-22
Sponsor Name: AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
Full Title: Effect of Cannabis Based Medicine Extract Sativex on brain function as assessed by fMRI and neurophysiologic evaluation in patients with Multiple Sclerosis a double blind, randomised, placebo-co...
Medical condition: Treatment of spasticity in patients with Multiple Sclerosis
Disease: Version SOC Term Classification Code Term Level
9.1 10028245 Multiple sclerosis LLT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-002125-42 Sponsor Protocol Number: CTH9507J Start Date: 2004-09-22
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
Full Title: EFFECT OF PROLONGED TREATMENT WITH TH9507 ON IGF-I LEVELS IN ADOLESCENTS WITH ISOLATED GH DEFICIENCY DUE TO HYPOTHALAMIC PATHOGENESIS
Medical condition: EVALUATION OF GROWTH HORMONE RELEASE
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-001967-24 Sponsor Protocol Number: L 9259 Start Date: 2004-09-22
Sponsor Name: Sanofi-Synthelabo Rt.
Full Title: Kiegészítő zolpidem kezelés friss antidepresszáns kezelés alatt álló disztimiás vagy depressziós betegek alvászavarának kezelésében
Medical condition: A depresszióban szenvedő betegek alvászavarára jellemzően megfigyelhető kóros alvásparaméterek lehetnek az elalvás nehezítettsége, töredezett, felszínes alvás gyakori felébredésekkel, az újra elalv...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed)
Trial results: View results
EudraCT Number: 2004-001091-40 Sponsor Protocol Number: 2-47-52030-722 Start Date: 2004-09-22
Sponsor Name: Beaufour Ipsen Pharma
Full Title: A Phase III, Prospective, Multicentre, Randomised, Open, Parallel Group Comparison of Lanreotide Autogel (90 and 120mg) Administered by Deep Subcutaneous Injection Every Four Weeks, with Sandostati...
Medical condition: Treatment of clinical symptoms of carcinoid syndrome.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: View results

EudraCT Number: 2004-000755-41 Sponsor Protocol Number: RA/PR/3301/010/03 Start Date: 2004-09-22
Sponsor Name: Chiesi Farmaceurtici S.p.A
Full Title: A three-month, double-blind, double dummy, parallel group, controlled study comparing the efficacy and safety between 12 µg twice daily of Formoterol-HFA and 12 µg twice daily of Formoterol-DPI (Fo...
Medical condition: Children Persistent Asthma
Disease: Version SOC Term Classification Code Term Level
7.0 10003553 Low
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: CZ (Completed)
Trial results: View results
EudraCT Number: 2007-005396-34 Sponsor Protocol Number: RG_10-040 Start Date: 2004-09-22
Sponsor Name: University of Birmingham
Full Title: Treatment Protocol for T-Cell and B-Precursor Cell Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL)
Medical condition: lymphoblastic lymphoma
Disease: Version SOC Term Classification Code Term Level
9.1 10065923 Lymphoblastic lymphoma LLT
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2004-000348-25 Sponsor Protocol Number: D6160C00031 Start Date: 2004-09-22
Sponsor Name: ASTRAZENECA
Full Title: GALLANT 8 - A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Added to the Th...
Medical condition: To prevent vascular disease associated with insulin resistence.
Disease: Version SOC Term Classification Code Term Level
9.1 10053247 Insulin-requiring type 2 diabetes mellitus LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-001033-41 Sponsor Protocol Number: H6D-MC-LVFZ Start Date: 2004-09-22
Sponsor Name: ELI LILLY
Full Title: A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evluate the Efficacy and Safety of Tadalafil (2.5 mg e 5 mg) administered once daily to men with diabetes mellitus and erect...
Medical condition: Therapy of erectile disfunction to subjects with diabetes mellitus and erectile disfunction with a 2.5 mg or 5 mg daily dosing.
Disease: Version SOC Term Classification Code Term Level
6.1 10061461 PT
Population Age: Adults, Elderly Gender: Male
Trial protocol: IT (Completed)
Trial results: (No results available)

EudraCT Number: 2004-001551-11 Sponsor Protocol Number: Iloprost Start Date: 2004-09-22
Sponsor Name: Lund University Hospital
Full Title: Behandling av förhöjt pulmonellt arteriellt tryck med inhalerad iloprost
Medical condition: Nyfödda barn som är i behov av respiratorvård pga RDS, mekoniumaspiration eller primär lunghypertension
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
Trial protocol: SE (Ongoing)
Trial results: (No results available)
3
Subskrybuj